The Scientist Turned VC Funding the Cure for Aging with Omri Amirav-Drory
Ventures from The Valley · 2026-02-04 · 1h 1m
Episode notes
What if aging isn’t inevitable — but a solvable problem? And what if the biggest opportunity in healthcare isn’t treating disease, but preventing it entirely? In this episode of Ventures from the Valley, I sit down with Omri Amirav-Drory, General Partner at NFX, to explore one of the most ambitious frontiers in venture capital: longevity, biotech, and the intersection of biology and technology. Omri leads pre-seed and seed investments at NFX and focuses on what he believes is the ultimate mission — ending involuntary death. We talk openly about why aging is the root cause behind most diseases, how AI is transforming biotech, and why longevity represents a $38 trillion per year opportunity in additional healthy life. This is a deep, honest conversation about conviction, risk, optimism, and why the future of healthcare looks nothing like today’s system.